Discovery & Preclinical
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
Drug development in many areas of immunology is thriving, with companies expanding their pipelines in cardiometabolic, auto-immune or kidney diseases. Various rare but devastating conditions are also the focus of the industry, with a number of orphan drugs rapidly progressing through clinical development.
tranScrip’s expertise covers small molecules as well as monoclonal antibodies, cell therapy, antisense oligo-nucleotides and gene therapy. We are helping our clients seize opportunities and meet their development goals by challenging the current clinical and regulatory paradigms.
We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.
Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence
Implement first-in-human trials, interpreting emerging data and adapting plans as needed. Ensure robust decisions, including clear proof-of-concept
Design medically-endorsed pivotal programs that stand up to global regulatory and commercial scrutiny. Navigate issues in implementation
Interpret data, assess benefit/risk and secure regulatory approvals, successfully bring your medicine to market. Ensure strong lifecycle management
Medical Director
Lawley Pharmaceuticals
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.
